Skip to main content
Top
Published in: Rheumatology International 6/2007

01-04-2007 | Original Article

Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes

Authors: Tomohiro Tanikawa, Yuko Waguri-Nagaya, Takuma Kusabe, Mineyoshi Aoyama, Kiyofumi Asai, Takanobu Otsuka

Published in: Rheumatology International | Issue 6/2007

Login to get access

Abstract

Gliostatin/thymidine phosphorylase (GLS/TP) is known to have angiogenic and arthritogenic activities. The purpose of this study was to elucidate whether GLS/TP is involved in the regulation of the angiogenic cytokine vascular endothelial growth factor (VEGF) in rheumatoid arthritis (RA). Fibroblast-like synoviocytes (FLSs) from patients with RA were cultured and stimulated with recombinant human GLS (rHuGLS) and interleukin (IL)-1β. Immunohistochemistry showed that GLS/TP and VEGF were detectable in the synovial lining cells. In cultured FLSs, both VEGF mRNA and protein levels were markedly increased by rHuIL-1β treatment. rHuGLS increased VEGF mRNA expression in a dose-dependent manner. We detected high concentrations of VEGF165 protein in culture supernatants from FLSs treated with rHuGLS (300 ng/ml), which were comparable to GLS levels found in synovial fluid of RA patients. These findings indicate that GLS/TP and VEGF have synergistic effects on angiogenesis in rheumatoid synovitis, and that GLS/TP has a role in regulating VEGF.
Literature
1.
go back to reference Colville-Nash PR, Scott DL (1992) Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 51:919–925PubMed Colville-Nash PR, Scott DL (1992) Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 51:919–925PubMed
3.
go back to reference Asai K, Nakanishi K, Isobe I et al (1992) Neurotrophic action of gliostatin on cortical neurons: identity of gliostatin and platelet-derived endothelial cell growth factor. J Biol Chem 267:20311–20316PubMed Asai K, Nakanishi K, Isobe I et al (1992) Neurotrophic action of gliostatin on cortical neurons: identity of gliostatin and platelet-derived endothelial cell growth factor. J Biol Chem 267:20311–20316PubMed
4.
go back to reference Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S (1992) Angiogenic factor. Nature 356:668PubMedCrossRef Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S (1992) Angiogenic factor. Nature 356:668PubMedCrossRef
5.
go back to reference Moghaddam A, Zhang H-T, Fan T-PF et al (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92:998–1002PubMedCrossRef Moghaddam A, Zhang H-T, Fan T-PF et al (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92:998–1002PubMedCrossRef
6.
go back to reference Miyadera K, Sumizawa T, Haraguchi M et al (1995) Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55:1687–1690PubMed Miyadera K, Sumizawa T, Haraguchi M et al (1995) Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55:1687–1690PubMed
7.
go back to reference Asai K, Hirano T, Kaneko S et al (1992) A novel glial growth inhibitory factor, gliostatin, derived from neurofibroma. J Neurochem 59:307–317PubMedCrossRef Asai K, Hirano T, Kaneko S et al (1992) A novel glial growth inhibitory factor, gliostatin, derived from neurofibroma. J Neurochem 59:307–317PubMedCrossRef
8.
go back to reference Ueki T, Nakanishi K, Asai K et al (1993) Neurotrophic action of gliostatin on cocultured neuron with glial cells. Brain Res 622:299–302PubMedCrossRef Ueki T, Nakanishi K, Asai K et al (1993) Neurotrophic action of gliostatin on cocultured neuron with glial cells. Brain Res 622:299–302PubMedCrossRef
9.
go back to reference Asai K, Hirano T, Matsukawa K et al (1993) High concentration of immunoreactive gliostatin/platelet-derived endothelial cell growth factor in synovial fluid and serum of rheumatoid arthritis. Clin Chim Acta 218:1–4PubMedCrossRef Asai K, Hirano T, Matsukawa K et al (1993) High concentration of immunoreactive gliostatin/platelet-derived endothelial cell growth factor in synovial fluid and serum of rheumatoid arthritis. Clin Chim Acta 218:1–4PubMedCrossRef
10.
go back to reference Takeuchi M, Otsuka T, Matsui N et al (1994) Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid arthritis. Arthritis Rheum 37:662–672PubMedCrossRef Takeuchi M, Otsuka T, Matsui N et al (1994) Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid arthritis. Arthritis Rheum 37:662–672PubMedCrossRef
11.
go back to reference Waguri Y, Otsuka T, Sugimura I et al (1997) Gliostatin/platelet-derived endothelial cell growth factor as a clinical marker of rheumatoid arthritis and its regulation in fibroblast like synoviocytes. Br J Rheumatol 36:315–321PubMedCrossRef Waguri Y, Otsuka T, Sugimura I et al (1997) Gliostatin/platelet-derived endothelial cell growth factor as a clinical marker of rheumatoid arthritis and its regulation in fibroblast like synoviocytes. Br J Rheumatol 36:315–321PubMedCrossRef
12.
go back to reference Muro H, Waguri-Nagaya Y, Mukofujiwara Y et al (1999) Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes. Rheumatol 38:1195–1202CrossRef Muro H, Waguri-Nagaya Y, Mukofujiwara Y et al (1999) Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes. Rheumatol 38:1195–1202CrossRef
13.
go back to reference Waguri-Nagaya Y, Otsuka T, Sugimura I et al (2000) Synovial inflammation and hyperplasia induced by gliostatin/platelet-derived endothelial cell growth factor in rabbit knees. Rheumatol Int 20:13–19PubMedCrossRef Waguri-Nagaya Y, Otsuka T, Sugimura I et al (2000) Synovial inflammation and hyperplasia induced by gliostatin/platelet-derived endothelial cell growth factor in rabbit knees. Rheumatol Int 20:13–19PubMedCrossRef
14.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
15.
go back to reference Szekanecz Z, Szegedi G, Koch AE (1998) Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Investig Med 46:27–41PubMed Szekanecz Z, Szegedi G, Koch AE (1998) Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. J Investig Med 46:27–41PubMed
16.
go back to reference Hirohata S, Sakakibara J (1999) Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis. Lancet 353:1331PubMedCrossRef Hirohata S, Sakakibara J (1999) Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis. Lancet 353:1331PubMedCrossRef
17.
18.
go back to reference Pufe T, Petersen W, Tillmann B, Mentlein R (2001) Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J Rheumatol 28:1482–1485PubMed Pufe T, Petersen W, Tillmann B, Mentlein R (2001) Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J Rheumatol 28:1482–1485PubMed
19.
go back to reference Lee SS, Joo YS, Kim WU et al (2001) Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19:321–324PubMed Lee SS, Joo YS, Kim WU et al (2001) Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19:321–324PubMed
20.
go back to reference Harada M, Mitsuyama K, Yoshida H et al (1998) Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 27:377–380PubMedCrossRef Harada M, Mitsuyama K, Yoshida H et al (1998) Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 27:377–380PubMedCrossRef
21.
go back to reference Koch AE, Harlow LA, Haines GK et al (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149–4156 Koch AE, Harlow LA, Haines GK et al (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149–4156
22.
go back to reference Fava RA, Olsen NJ, Spencer-Green G et al (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341–346PubMedCrossRef Fava RA, Olsen NJ, Spencer-Green G et al (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341–346PubMedCrossRef
23.
go back to reference Nagashima M, Yoshino S, Ishiwata T, Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22:1624–1630PubMed Nagashima M, Yoshino S, Ishiwata T, Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22:1624–1630PubMed
24.
go back to reference Berse B, Hunt JA, Diegel RJ et al (1999) Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 115:176–182PubMedCrossRef Berse B, Hunt JA, Diegel RJ et al (1999) Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 115:176–182PubMedCrossRef
25.
go back to reference Ikeda N, Adachi M, Taki T et al (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553–1563PubMedCrossRef Ikeda N, Adachi M, Taki T et al (1999) Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553–1563PubMedCrossRef
26.
go back to reference Maeda K, Kang SM, Ogawa M et al (1997) Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer 74:545–550PubMedCrossRef Maeda K, Kang SM, Ogawa M et al (1997) Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer 74:545–550PubMedCrossRef
27.
go back to reference O’byrne KJ, Koukourakis MI, Giatromanolaki A et al (2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 82:1427–1432PubMed O’byrne KJ, Koukourakis MI, Giatromanolaki A et al (2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 82:1427–1432PubMed
28.
go back to reference Toi M, Inada K, Hoshina S, Suzuki H, Kondo S, Tominaga T (1995) Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1:961–964PubMed Toi M, Inada K, Hoshina S, Suzuki H, Kondo S, Tominaga T (1995) Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1:961–964PubMed
29.
go back to reference Seki N, Kodama J, Hongo A, Miyagi Y, Yoshinouchi M, Kudo T (2000) Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer. Eur J Cancer 36:68–73PubMedCrossRef Seki N, Kodama J, Hongo A, Miyagi Y, Yoshinouchi M, Kudo T (2000) Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer. Eur J Cancer 36:68–73PubMedCrossRef
30.
go back to reference Firestein GS, Paine MM (1992) Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 140:1309–1314PubMed Firestein GS, Paine MM (1992) Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 140:1309–1314PubMed
31.
go back to reference Maeda S, Sawai T, Uzuki M et al (1995) Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 54:970–975PubMedCrossRef Maeda S, Sawai T, Uzuki M et al (1995) Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 54:970–975PubMedCrossRef
Metadata
Title
Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes
Authors
Tomohiro Tanikawa
Yuko Waguri-Nagaya
Takuma Kusabe
Mineyoshi Aoyama
Kiyofumi Asai
Takanobu Otsuka
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0258-5

Other articles of this Issue 6/2007

Rheumatology International 6/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.